Comparing the Safety and Efficiency of Conventional Monopolar, Plasmakinetic, and Holmium Laser Transurethral Resection of Primary Non-muscle Invasive Bladder Cancer
- 1 January 2010
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Endourology
- Vol. 24 (1), 69-73
- https://doi.org/10.1089/end.2009.0171
Abstract
Purpose: To compare the safety and efficiency of conventional monopolar, plasmakinetic and holmium laser transurethral resection of bladder tumor (CM-TURBT, PK-TURBT and HoL-TURBT) while managing primary non-muscle invasive bladder cancer. Patients and Methods: From 2005 to 2009, 173 patients with primary non-muscle invasive bladder cancer underwent endoscopic surgery. Among them, 51 patients underwent CM-TURBT, 58 patients underwent PK-TURBT, and 64 patients underwent HoL-TURBT. All patients were divided into three risk groups (low, intermediate, and high) based on the European Association of Urology guidelines and prognostic factors of recurrence. Clinical data, included preoperative, operative, and postoperative management and follow-up, were recorded. Results: Patient demographics and tumor characteristics in all three groups were compared before surgery. There was no significant difference in operative duration among the three groups. Compared with the CM-TURBT group, both PK-TURBT and HoL-TURBT groups had less intraoperative and postoperative complications, including obturator nerve reflex, bladder perforation, as well as bleeding and postoperative bladder irritation. There were no significant differences among the three groups in the transfusion rate and occurrence of urethral strictures. Patients in the PK-TURBT and HoL-TURBT groups had less catheterization and hospitalization time than those in the CM-TURBT group, and there were no significant differences in each risk subgroup as well as the overall recurrence rate among the CM-TURBT, PK-TURBT and HoL-TURBT groups. Conclusions: Both PK-TURBT and HoL-TURBT might prove to be preferable alternatives to CM-TURBT management of non-muscle invasive bladder cancer. PK-TURBT and HoL-TURBT, however, did not demonstrate an obvious advantage over CM-TURBT in tumor recurrence rate.Keywords
This publication has 18 references indexed in Scilit:
- Safety and Efficacy of Holmium Laser Resection for Primary Nonmuscle-Invasive Bladder Cancer Versus Transurethral Electroresection: Single-Center ExperienceUrology, 2008
- Technological Advances in Transurethral Resection of the Prostate: Bipolar versus Monopolar TURPJournal of Endourology, 2008
- Use of Bipolar Energy for Transurethral Resection of Superficial Bladder Tumors: Long-Term ResultsJournal of Endourology, 2008
- Holmium Laser Treatment for Low Grade, Low Stage, Noninvasive Bladder Cancer With Local Anesthesia and Early Instillation of Mitomycin CJournal of Urology, 2007
- Recent improvements in the detection and treatment of nonmuscle-invasive bladder cancerExpert Review of Anticancer Therapy, 2006
- Recent improvements in transurethral high‐frequency electrosurgery of the prostateBJU International, 2006
- TRANSURETHRAL BLADDER TUMOR RESECTION: INTRAOPERATIVE AND POSTOPERATIVE COMPLICATIONS IN A RESIDENCY SETTINGJournal of Urology, 2005
- Plasma bubble formation induced by holmium laserUrology, 2005
- Transurethral Resection Syndrome After Bladder PerforationAnesthesia & Analgesia, 2003
- Gyrus™ bipolar electrovaporization vs transurethral resection of the prostate: a randomized prospective single-blind trial with 1 y follow-upProstate Cancer and Prostatic Diseases, 2003